Lung CancerNCT00499330
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
A study testing lobectomy and segmentectomy or wedge resection in people with Lung Cancer, run by Alliance for Clinical Trials in Oncology at 386 sites in 3 countries.
Trial summary
RATIONALE: Wedge resection or segmentectomy may be less invasive types of surgery than lobectomy for non-small cell lung cancer and may have fewer side effects and improve recovery. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Lung Cancer
- What is being tested?
- lobectomy and segmentectomy or wedge resection
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- Not given
- Where
- 386 sitesin 3 countries
- Study dates
- 12 Oct 2007to 4 Apr 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Pre-registration Eligibility Criteria:
- Peripheral lung nodule ≤ 2 cm on preoperative CT scan and presumed to be lung cancer. The center of the tumor, as seen on CT, must be located in the outer third of the lung in either the transverse, coronal or sagittal plane. Patients with pure ground glass opacities or pathologically confirmed N1 or N2 disease are not eligible.
- The tumor location must be suitable for either lobar or sublobar resection (wedge or segment).
- ECOG performance status of 0-2.
- No prior malignancy within 3 years other than non-melanoma skin cancer, superficial bladder cancer, or CIS of the cervix.
- No prior chemotherapy or radiation therapy for this malignancy.
- No evidence of locally advanced or metastatic disease.
- Age ≥ 18 years
Intra-operative Randomization Eligibility Criteria:
- Histologic confirmation of NSCLC (if not already obtained)
- Confirmation of N0 status by frozen section examination. Right sided tumors require that node levels 4, 7, and 10 be sampled and diagnosed as negative on frozen section. Left sided tumors require that node levels 5 or 6, 7 and 10 be sampled and diagnosed as negative on frozen section. Levels 4 and 7 nodes may be sampled by mediastinoscopy, endobronchial ultrasound (EBUS) and/or endoscopic ultrasound (EUS), or at the time of thoracotomy or VATS exploration. Nodes previously sampled by mediastinoscopy (or EBUS and/or EUS) either immediately prior to or within 6 weeks of the definitive surgical procedure (thoracotomy or VATS) do not need to be resampled.
Trial locations and contacts
386 sites in 3 countries.
313 sites in 3 countries
United States300 sites
Providence Regional Cancer System-Aberdeen
Aberdeen, Washington, 98520
Lehigh Valley Hospital-Cedar Crest
Allentown, Pennsylvania, 18103
American Fork Hospital / Huntsman Intermountain Cancer Center
American Fork, Utah, 84003
Community Hospital of Anaconda
Anaconda, Montana, 59711
Cancer Care Center at Island Hospital
Anacortes, Washington, 98221
Anchorage Associates in Radiation Medicine
Anchorage, Alaska, 98508
Anchorage Radiation Therapy Center
Anchorage, Alaska, 99504
Alaska Breast Care and Surgery LLC
Anchorage, Alaska, 99508
Alaska Oncology and Hematology LLC
Anchorage, Alaska, 99508
Alaska Regional Hospital
Anchorage, Alaska, 99508
Alaska Women's Cancer Care
Anchorage, Alaska, 99508
Anchorage Oncology Centre
Anchorage, Alaska, 99508
Katmai Oncology Group
Anchorage, Alaska, 99508
Providence Alaska Medical Center
Anchorage, Alaska, 99508
Saint Joseph Mercy Hospital
Ann Arbor, Michigan, 48106-0995
Michigan Cancer Research Consortium NCORP
Ann Arbor, Michigan, 48106
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, 48109
Anne Arundel Medical Center
Annapolis, Maryland, 21401
Fox Valley Surgical Associates Limited
Appleton, Wisconsin, 54911
Asheville VA Medical Center
Asheville, North Carolina, 28805
Emory University Hospital Midtown
Atlanta, Georgia, 30308
Emory University/Winship Cancer Institute
Atlanta, Georgia, 30322
MultiCare Auburn Medical Center
Auburn, Washington, 98001
University of Colorado Cancer Center - Anschutz Cancer Pavilion
Aurora, Colorado, 80045
Saint Alphonsus Medical Center-Baker City
Baker City, Oregon, 97814
University of Maryland/Greenebaum Cancer Center
Baltimore, Maryland, 21201
Flaget Memorial Hospital
Bardstown, Kentucky, 40004
Memorial Sloan Kettering Cancer Center at Basking Ridge
Basking Ridge, New Jersey, 07920
Upper Chesapeake Medical Center
Bel Air, Maryland, 21014
Mary Rutan Hospital
Bellefontaine, Ohio, 43311
Overlake Hospital Medical Center
Bellevue, Washington, 98004
Swedish Cancer Institute-Eastside Oncology Hematology
Bellevue, Washington, 98005
PeaceHealth Saint Joseph Medical Center
Bellingham, Washington, 98225
Saint Charles Health System
Bend, Oregon, 97701
Central Vermont Medical Center/National Life Cancer Treatment
Berlin Corners, Vermont, 05602
Lehigh Valley Hospital - Muhlenberg
Bethlehem, Pennsylvania, 18017
Billings Clinic Cancer Center
Billings, Montana, 59101
Saint Vincent Healthcare
Billings, Montana, 59101
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, 35233
Boca Raton Regional Hospital
Boca Raton, Florida, 33486
Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, 83706
Saint Luke's Mountain States Tumor Institute
Boise, Idaho, 83712
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114
Brigham and Women's Hospital
Boston, Massachusetts, 02115
Boston Medical Center
Boston, Massachusetts, 02118
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215
Bozeman Deaconess Hospital
Bozeman, Montana, 59715
Harrison HealthPartners Hematology and Oncology-Bremerton
Bremerton, Washington, 98310
Harrison Medical Center
Bremerton, Washington, 98310
Ocean Medical Center
Brick, New Jersey, 08724
Saint Vincent's Medical Center
Bridgeport, Connecticut, 06606
IHA Hematology Oncology Consultants-Brighton
Brighton, Michigan, 48114
Saint Joseph Mercy Brighton
Brighton, Michigan, 48114
Saint Joseph Regional Cancer Center
Bryan, Texas, 77802
Roswell Park Cancer Institute
Buffalo, New York, 14263
Providence Saint Joseph Medical Center/Disney Family Cancer Center
Burbank, California, 91505
Highline Medical Center-Main Campus
Burien, Washington, 98166
University of Vermont College of Medicine
Burlington, Vermont, 05405
Saint James Community Hospital and Cancer Treatment Center
Butte, Montana, 59701
Saint Alphonsus Cancer Care Center-Caldwell
Caldwell, Idaho, 83605
Cooper Hospital University Medical Center
Camden, New Jersey, 08103
IHA Hematology Oncology Consultants-Canton
Canton, Michigan, 48188
Saint Joseph Mercy Canton Health Center
Canton, Michigan, 48188
Mercy Medical Center
Canton, Ohio, 44708
Southeast Missouri Hospital
Cape Girardeau, Missouri, 63701
Mercy San Juan Medical Center
Carmichael, California, 95608
Caro Cancer Center
Caro, Michigan, 48723
Providence Regional Cancer System-Centralia
Centralia, Washington, 98531
Medical University of South Carolina
Charleston, South Carolina, 29425
University of Virginia Cancer Center
Charlottesville, Virginia, 22908
Memorial Hospital
Chattanooga, Tennessee, 37404
IHA Hematology Oncology Consultants-Chelsea
Chelsea, Michigan, 48118
Saint Joseph Mercy Chelsea
Chelsea, Michigan, 48118
University of Chicago Comprehensive Cancer Center
Chicago, Illinois, 60637
Adena Regional Medical Center
Chillicothe, Ohio, 45601
Good Samaritan Hospital - Cincinnati
Cincinnati, Ohio, 45220
Bethesda North Hospital
Cincinnati, Ohio, 45242
TriHealth Cancer Institute-Westside
Cincinnati, Ohio, 45247
TriHealth Cancer Institute-Anderson
Cincinnati, Ohio, 45255
Clackamas Radiation Oncology Center
Clackamas, Oregon, 97015
Providence Oncology and Hematology Care Southeast
Clackamas, Oregon, 97015
Hematology Oncology Consultants-Clarkston
Clarkston, Michigan, 48346
Newland Medical Associates-Clarkston
Clarkston, Michigan, 48346
Southeastern Medical Oncology Center-Clinton
Clinton, North Carolina, 28328
Medical Oncology and Hematology Associates-West Des Moines
Clive, Iowa, 50325
Mercy Cancer Center-West Lakes
Clive, Iowa, 50325
Big Horn Basin Cancer Center
Cody, Wyoming, 82414
Billings Clinic-Cody
Cody, Wyoming, 82414
Kootenai Medical Center
Coeur d'Alene, Idaho, 83814
Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, 80907
Rocky Mountain Cancer Centers-Penrose
Colorado Springs, Colorado, 80907
Memorial Hospital Colorado Springs
Colorado Springs, Colorado, 80909
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210
Riverside Methodist Hospital
Columbus, Ohio, 43214
Columbus NCI Community Oncology Research Program
Columbus, Ohio, 43215
Grant Medical Center
Columbus, Ohio, 43215
The Mark H Zangmeister Center
Columbus, Ohio, 43219
Mount Carmel Health Center West
Columbus, Ohio, 43222
Doctors Hospital
Columbus, Ohio, 43228
Memorial Sloan Kettering Commack
Commack, New York, 11725
Bay Area Hospital
Coos Bay, Oregon, 97420
Commonwealth Cancer Center-Corbin
Corbin, Kentucky, 40701
Alegent Health Mercy Hospital
Council Bluffs, Iowa, 51503
Greater Regional Medical Center
Creston, Iowa, 50801
Medical City Dallas Hospital
Dallas, Texas, 75230
UT Southwestern/Simmons Cancer Center-Dallas
Dallas, Texas, 75390
Geisinger Medical Center
Danville, Pennsylvania, 17822
Beaumont Hospital-Dearborn
Dearborn, Michigan, 48124
Atlanta VA Medical Center
Decatur, Georgia, 30033
Grady Memorial Hospital
Delaware, Ohio, 43015
Porter Adventist Hospital
Denver, Colorado, 80210
University of Colorado
Denver, Colorado, 80217-3364
Medical Oncology and Hematology Associates-Laurel
Des Moines, Iowa, 50314
Mercy Medical Center - Des Moines
Des Moines, Iowa, 50314
Henry Ford Hospital
Detroit, Michigan, 48202
Saint John Hospital and Medical Center
Detroit, Michigan, 48236
Mercy Medical Center
Durango, Colorado, 81301
Southwest Oncology PC
Durango, Colorado, 81301
Duke University Medical Center
Durham, North Carolina, 27710
Greenville Health System Cancer Institute-Easley
Easley, South Carolina, 29640
Great Lakes Cancer Management Specialists-Doctors Park
East China, Michigan, 48054
Hematology Oncology Associates of Central New York-East Syracuse
East Syracuse, New York, 13057
Memorial Sloan-Kettering Cancer Center West Harrison
East White Plains, New York, 10604
John F Kennedy Medical Center
Edison, New Jersey, 08818
Swedish Medical Center-Edmonds
Edmonds, Washington, 98026
Union Hospital of Cecil County
Elkton, Maryland, 21921
Walter Knox Memorial Hospital
Emmett, Idaho, 83617
Saint Elizabeth Hospital
Enumclaw, Washington, 98022
Providence Regional Cancer Partnership
Everett, Washington, 98201
Saint Francis Hospital
Federal Way, Washington, 98003
Hurley Medical Center
Flint, Michigan, 48502
Genesee Cancer and Blood Disease Treatment Center
Flint, Michigan, 48503
Genesee Hematology Oncology PC
Flint, Michigan, 48503
Genesys Hurley Cancer Institute
Flint, Michigan, 48503
Genesys Regional Medical Center-West Flint Campus
Flint, Michigan, 48532
The New York Hospital Medical Center of Queens
Flushing, New York, 11355
Mary Washington Hospital
Fredericksburg, Virginia, 22401
Saint Luke's Mountain States Tumor Institute - Fruitland
Fruitland, Idaho, 83619
Saint Jude Medical Center
Fullerton, California, 92835
Mountain Blue Cancer Care Center
Golden, Colorado, 80401
Southeastern Medical Oncology Center-Goldsboro
Goldsboro, North Carolina, 27534
Wayne Memorial Hospital
Goldsboro, North Carolina, 27534
Lymphoma Clinic of Michigan
Gorsse Pointe Woods, Michigan, 48236
Genesys Regional Medical Center
Grand Blanc, Michigan, 48439
CHI Health Saint Francis
Grand Island, Nebraska, 68803
Benefis Healthcare- Sletten Cancer Institute
Great Falls, Montana, 59405
Big Sky Oncology
Great Falls, Montana, 59405
Great Falls Clinic
Great Falls, Montana, 59405
Greenville Health System Cancer Institute-Butternut
Greenville, South Carolina, 29605
Greenville Memorial Hospital
Greenville, South Carolina, 29605
Great Lakes Cancer Management Specialists-Van Elslander Cancer Center
Grosse Pointe Woods, Michigan, 48236
Michigan Breast Specialists-Grosse Pointe Woods
Grosse Pointe Woods, Michigan, 48236
Sentara Cancer Institute at Sentara CarePlex Hospital
Hampton, Virginia, 23666
Virginia Oncology Associates-Hampton
Hampton, Virginia, 23666
Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, 06105
Saint Peter's Community Hospital
Helena, Montana, 59601
Pulmonary Medicine Center of Chattanooga-Hixson
Hixson, Tennessee, 37343
Mercy Cancer Center-Hot Springs
Hot Springs, Arkansas, 71913
M D Anderson Cancer Center
Houston, Texas, 77030
Indiana University/Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, 46202
Richard L. Roudebush Veterans Affairs Medical Center
Indianapolis, Indiana, 46202
Sidney and Lois Eskenazi Hospital
Indianapolis, Indiana, 46202
Swedish Cancer Institute-Issaquah
Issaquah, Washington, 98029
Allegiance Health
Jackson, Michigan, 49201
Mayo Clinic in Florida
Jacksonville, Florida, 32224-9980
Southeastern Medical Oncology Center-Jacksonville
Jacksonville, North Carolina, 28546
Kalispell Regional Medical Center
Kalispell, Montana, 59901
University of Kansas Cancer Center
Kansas City, Kansas, 66160
Truman Medical Center
Kansas City, Missouri, 64108
Saint Luke's Hospital of Kansas City
Kansas City, Missouri, 64111
Saint Joseph Health Center
Kansas City, Missouri, 64114
North Kansas City Hospital
Kansas City, Missouri, 64116
Heartland Hematology and Oncology Associates Incorporated
Kansas City, Missouri, 64118
Research Medical Center
Kansas City, Missouri, 64132
Heartland Hematology and Oncology
Kearney, Nebraska, 68845
CHI Health Good Samaritan
Kearney, Nebraska, 68847
Kadlec Clinic Hematology and Oncology
Kennewick, Washington, 99336
Seattle Cancer Care Alliance at EvergreenHealth
Kirkland, Washington, 98034
Armstrong Center for Medicine and Health
Kittanning, Pennsylvania, 16201
University of Tennessee - Knoxville
Knoxville, Tennessee, 37920
Providence Regional Cancer System-Lacey
Lacey, Washington, 98503
Rocky Mountain Cancer Centers-Lakewood
Lakewood, Colorado, 80228
Saint Anthony Hospital
Lakewood, Colorado, 80228
Saint Clare Hospital
Lakewood, Washington, 98499
Fairfield Medical Center
Lancaster, Ohio, 43130
Sparrow Hospital
Lansing, Michigan, 48912
Saint Luke's East - Lee's Summit
Lee's Summit, Missouri, 64086
Beebe Medical Center
Lewes, Delaware, 19958
Geisinger Medical Oncology-Lewisburg
Lewisburg, Pennsylvania, 17837
Saint Joseph Regional Medical Center
Lewiston, Idaho, 83501
Saint Joseph Radiation Oncology Resource Center
Lexington, Kentucky, 40504
Saint Joseph Hospital East
Lexington, Kentucky, 40509
University of Kentucky/Markey Cancer Center
Lexington, Kentucky, 40536
Liberty Radiation Oncology Center
Liberty, Missouri, 64068
Saint Elizabeth Regional Medical Center
Lincoln, Nebraska, 68510
University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205
Littleton Adventist Hospital
Littleton, Colorado, 80122
Hope Cancer Clinic
Livonia, Michigan, 48154
Saint Mary Mercy Hospital
Livonia, Michigan, 48154
Loma Linda University Medical Center
Loma Linda, California, 92354
Veterans Affairs Loma Linda Healthcare System
Loma Linda, California, 92357
Veterans Administration Long Beach Medical Center
Long Beach, California, 90822
Longmont United Hospital
Longmont, Colorado, 80501
Rocky Mountain Cancer Centers-Longmont
Longmont, Colorado, 80501
PeaceHealth Saint John Medical Center
Longview, Washington, 98632
Jewish Hospital
Louisville, Kentucky, 40202
Saints Mary and Elizabeth Hospital
Louisville, Kentucky, 40215
Jewish Hospital Medical Center Northeast
Louisville, Kentucky, 40245
Hematology Oncology Associates East PC
Macomb, Michigan, 48044
Michigan Breast Specialists-Macomb Township
Macomb, Michigan, 48044
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, 53792
Southern Ocean County Medical Center
Manahawkin, New Jersey, 08050
Marietta Memorial Hospital
Marietta, Ohio, 45750
Idaho Urologic Institute-Meridian
Meridian, Idaho, 83642
Saint Luke's Mountain States Tumor Institute - Meridian
Meridian, Idaho, 83642
Froedtert and the Medical College of Wisconsin
Milwaukee, Wisconsin, 53226
Providence Milwaukie Hospital
Milwaukie, Oregon, 97222
Memorial Regional Cancer Center Day Road
Mishawaka, Indiana, 46544
Saint Patrick Hospital - Community Hospital
Missoula, Montana, 59802
Community Medical Hospital
Missoula, Montana, 59804
Forbes Hospital
Monroeville, Pennsylvania, 15146
Knox Community Hospital
Mount Vernon, Ohio, 43050
Skagit Valley Hospital
Mount Vernon, Washington, 98274
Saint Alphonsus Medical Center-Nampa
Nampa, Idaho, 83686
Saint Luke's Mountain States Tumor Institute - Nampa
Nampa, Idaho, 83686
Allegheny Valley Hospital
Natrona Heights, Pennsylvania, 15065
Jersey Shore Medical Center
Neptune City, New Jersey, 07753
Jameson Health System North Campus
New Castle, Pennsylvania, 16105
Ochsner Medical Center Jefferson
New Orleans, Louisiana, 70121
Laura and Isaac Perlmutter Cancer Center at NYU Langone
New York, New York, 10016
Memorial Sloan-Kettering Cancer Center
New York, New York, 10065
Weill Medical College of Cornell University
New York, New York, 10065
Christiana Gynecologic Oncology LLC
Newark, Delaware, 19713
Delaware Clinical and Laboratory Physicians PA
Newark, Delaware, 19713
Helen F Graham Cancer Center
Newark, Delaware, 19713
Medical Oncology Hematology Consultants PA
Newark, Delaware, 19713
Regional Hematology and Oncology PA
Newark, Delaware, 19713
Christiana Care Health System-Christiana Hospital
Newark, Delaware, 19718
Licking Memorial Hospital
Newark, Ohio, 43055
Providence Newberg Medical Center
Newberg, Oregon, 97132
Virginia Oncology Associates - Lake Wright
Norfolk, Virginia, 23502
Sentara Norfolk General Hospital
Norfolk, Virginia, 23507
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104
Olathe Cancer Center
Olathe, Kansas, 66061
Providence - Saint Peter Hospital
Olympia, Washington, 98506-5166
Alegent Health Immanuel Medical Center
Omaha, Nebraska, 68122
Hemotology and Oncology Consultants PC
Omaha, Nebraska, 68122
Alegent Health Bergan Mercy Medical Center
Omaha, Nebraska, 68124
Alegent Health Lakeside Hospital
Omaha, Nebraska, 68130
Creighton University Medical Center
Omaha, Nebraska, 68131
University of Nebraska Medical Center
Omaha, Nebraska, 68198
Saint Alphonsus Medical Center-Ontario
Ontario, Oregon, 97914
Memorial GYN Plus
Ooltewah, Tennessee, 37363
UC Irvine Health/Chao Family Comprehensive Cancer Center
Orange, California, 92868
Providence Willamette Falls Medical Center
Oregon City, Oregon, 97045
Menorah Medical Center
Overland Park, Kansas, 66209
Saint Luke's South Hospital
Overland Park, Kansas, 66213
Midlands Community Hospital
Papillion, Nebraska, 68046
The Valley Hospital-Luckow Pavilion
Paramus, New Jersey, 07652
Parker Adventist Hospital
Parker, Colorado, 80138
Rocky Mountain Cancer Centers-Parker
Parker, Colorado, 80138
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, 19107
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111
Allegheny General Hospital
Pittsburgh, Pennsylvania, 15212
UPMC-Magee Womens Hospital
Pittsburgh, Pennsylvania, 15213
UPMC-Presbyterian Hospital
Pittsburgh, Pennsylvania, 15213
UPMC-Saint Margaret
Pittsburgh, Pennsylvania, 15215
West Penn Hospital
Pittsburgh, Pennsylvania, 15224
University of Pittsburgh Cancer Institute (UPCI)
Pittsburgh, Pennsylvania, 15232
UPMC-Shadyside Hospital
Pittsburgh, Pennsylvania, 15232
UPMC-Passavant Hospital
Pittsburgh, Pennsylvania, 15237
Berkshire Hematology Oncology PC
Pittsfield, Massachusetts, 01201
Portneuf Medical Center
Pocatello, Idaho, 83201
21st Century Oncology-Pontiac
Pontiac, Michigan, 48341
Hope Cancer Center
Pontiac, Michigan, 48341
Newland Medical Associates-Pontiac
Pontiac, Michigan, 48341
Saint Joseph Mercy Oakland
Pontiac, Michigan, 48341
Lake Huron Medical Center
Port Huron, Michigan, 48060
Providence Portland Medical Center
Portland, Oregon, 97213
Providence Saint Vincent Medical Center
Portland, Oregon, 97225
Portland Veterans Administration Medical Center
Portland, Oregon, 97239
Southern Ohio Medical Center
Portsmouth, Ohio, 45662
Kootenai Cancer Center
Post Falls, Idaho, 83854
Geisinger Medical Oncology-Pottsville
Pottsville, Pennsylvania, 17901
Harrison HealthPartners Hematology and Oncology-Poulsbo
Poulsbo, Washington, 98370
Saint Mary Corwin Medical Center
Pueblo, Colorado, 81004
Rocky Mountain Cancer Centers - Pueblo
Pueblo, Colorado, 81008
MultiCare Good Samaritan Hospital
Puyallup, Washington, 98372
Penn State Health Saint Joseph Medical Center
Reading, Pennsylvania, 19605
Riverview Medical Center/Booker Cancer Center
Red Bank, New Jersey, 07701
Beebe Health Campus
Rehoboth Beach, Delaware, 19971
Virginia Commonwealth University/Massey Cancer Center
Richmond, Virginia, 23298
Valley Hospital
Ridgewood, New Jersey, 07450
Kaiser Permanente-Riverside
Riverside, California, 92505
Mayo Clinic
Rochester, Minnesota, 55905
University of Rochester
Rochester, New York, 14642
Great Lakes Cancer Management Specialists-Rochester Hills
Rochester Hills, Michigan, 48309
Memorial Sloan Kettering Rockville Centre
Rockville Centre, New York, 11570
Highlands Oncology Group-Rogers
Rogers, Arkansas, 72758
University of California Davis Comprehensive Cancer Center
Sacramento, California, 95817
Canada12 sites
QEII Health Sciences Centre/Capital District Health Authority
Halifax, Nova Scotia, B3H 1V8
Saint Joseph's Healthcare Charlton Campus
Hamilton, Ontario, L8N 4A6
London Regional Cancer Program
London, Ontario, N6A 4L6
The Moncton Hospital
Moncton, New Brunswick, E1C 6Z8
CIUSSSEMTL-Hopital Maisonneuve-Rosemont
Montreal, Quebec, H1T 2M4
CHUM - Hopital Notre-Dame
Montreal, Quebec, H2L 4M1
Ottawa Hospital and Cancer Center-General Campus
Ottawa, Ontario, K1H 8L6
University Institute of Cardiology and Pneumology of Quebec (Laval Hospital)
Québec, Quebec, G1V 4G5
Centre Hospitalier Universitaire de Sherbrooke-Fleurimont
Sherbrooke, Quebec, J1H 5N4
Surrey Memorial Hospital
Surrey, British Columbia, V3V 1Z2
University Health Network-Princess Margaret Hospital
Toronto, Ontario, M5G 2M9
Saint Joseph's Health Centre
Toronto, Ontario, M6R 1B5
About this study
Official title: A Phase III Randomized Trial of Lobectomy Versus Sublobar Resection for Small (≤ 2 cm) Peripheral Non-Small Cell Lung Cancer
RATIONALE: Wedge resection or segmentectomy may be less invasive types of surgery than lobectomy for non-small cell lung cancer and may have fewer side effects and improve recovery. It is not yet known whether wedge resection or segmentectomy are more effective than lobectomy in treating stage IA non-small cell lung cancer.
PURPOSE: This randomized phase III trial is studying different types of surgery to compare how well they work in treating patients with stage IA non-small cell lung cancer.
Read the detailed description
OUTLINE: This is a multicenter, randomized study. Patients are stratified according to tumor size (< 1 cm vs 1-1.5 cm vs > 1.5-2.0 cm) (based on the maximum dimension determined from the preoperative CT scan), histology (squamous cell carcinoma vs adenocarcinoma vs other), and smoking status (never smoked [smoked < 100 cigarettes over lifetime] vs former smoker [smoked > 100 cigarettes AND quit ≥ 1 year ago] vs current smoker [quit < 1 year ago or currently smokes]). Patients are randomized to 1 of 2 treatment arms. For more information, please see the Arms section.
Primary Objective:
To determine whether DFS after sublobar resection (segmentectomy or wedge) is non-inferior to that after lobectomy in patients with small peripheral (≤ 2 cm) NSCLC.
Secondary Objectives:
- To determine whether overall survival (OS) (after sublobar resection) is non-inferior to that after lobectomy.
- To determine the rates of loco-regional and systemic recurrence (exclusive of second primaries) after lobar and sublobar resection.
- To determine the difference between the two arms of the study in pulmonary function as determined by expiratory flow rates measured at 6 months post-operatively.
- Imaging Substudy: To explore the relationship between characteristics of the primary lung cancer, as revealed by pre-operative CT and PET imaging, and outcomes; a determination of the false-negative rate of the pre-operative PET scan for identification of involved hilarand mediastinal lymph nodes; and an assessment of the utility of annual follow-up CT imaging after surgical resection of small stage IA NSCLC.
After completion of study treatment, patients are followed up every 6 months for 2 years and then annually for 5 years.
- Conditions
- Lung Cancer
- Being tested
- lobectomy, segmentectomy or wedge resection
- Keywords
- stage IA non-small cell lung cancer, adenocarcinoma of the lung, squamous cell lung cancer, large cell lung cancer, adenosquamous cell lung cancer, bronchoalveolar cell lung cancer
- Medical subject headings
- Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
lobectomyProcedure or surgery
segmentectomy or wedge resectionProcedure or surgery
| Study group | Role | What they receive |
|---|---|---|
| Arm A | Other | Patients undergo a standard operation for lung cancer called a lobectomy. Receives: Procedure: lobectomy |
| Arm B | Experimental | Patents undergo a limited resection (segentectomy or wedge resection), which a smaller portion of the lung is removed. Receives: Procedure: segmentectomy or wedge resection |
What is being measured
The primary outcome is the main question the study is designed to answer.
disease-free survival
Measured: Up to 7 years
Secondary outcomes (3)
overall survival
Measured: Up to 7 years
rate of loco-regional and systemic recurrence
Measured: Up to 7 years
pulmonary function as measured by expiratory flow rate 6 months postoperatively
Measured: at 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Jul 2007 (estimated)
- Study start12 Oct 2007
- Primary completion4 Apr 2027 (estimated)
- Study completion4 Apr 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (5)Papers the sponsor has linked to this study.
- Other trials for Lung CancerStudies of the same condition, open and under way.
- More trials run by Alliance for Clinical Trials in OncologyThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
Sponsor and investigators
- Lead sponsor
- Alliance for Clinical Trials in Oncology
- Sponsor type
- University, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- Responsible party
- Sponsor
- Investigators
- Nasser Altorki, MD, Study chair, Weill Medical College of Cornell University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00499330
- Sponsor's protocol ID
- CALGB 140503
- Other IDs
- CALGB-140503, CDR0000555324, NCI-2009-00447
- Status last verified
- Jul 2026
- First submitted
- 10 Jul 2007
- Last updated
- 16 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
Publications
Ganti AK, Damman B, Wang X, Stinchcombe TE, Altorki N. Outcomes Based on Age in CALGB 140503 (Alliance): Lobar Versus Sublobar Resection for Peripheral Stage IA Non-small Cell Lung Cancer. Clin Lung Cancer. 2026 Jul 2;27(7):42-49. doi: 10.1016/j.cllc.2026.06.009. Online ahead of print.
PubMed 42501610Altorki N, Damman B, Wang X, Liberman M, Wigle D, Ashrafi A, Conti M, Yasufuku K, Schuchert MJ, Stinchcombe TE. The extent of lymph node dissection is not associated with disease-free survival following lobar or sublobar resection: Results from Cancer and Leukemia Group B 140503 (Alliance). J Thorac Cardiovasc Surg. 2025 Oct;170(4):933-942.e2. doi: 10.1016/j.jtcvs.2025.06.007. Epub 2025 Jun 16.
PubMed 40532782Stinchcombe TE, Wang X, Damman B, Mentlick J, Landreneau R, Wigle D, Jones DR, Conti M, Ashrafi AS, Liberman M, de Perrot M, Mitchell JD, Keenan R, Bauer T, Miller D, Altorki N. Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung Cancer. J Clin Oncol. 2024 Apr 1;42(10):1110-1113. doi: 10.1200/JCO.23.01306. Epub 2024 Jan 12.
PubMed 38215351Altorki N, Wang X, Kozono D, Watt C, Landrenau R, Wigle D, Port J, Jones DR, Conti M, Ashrafi AS, Liberman M, Yasufuku K, Yang S, Mitchell JD, Pass H, Keenan R, Bauer T, Miller D, Kohman LJ, Stinchcombe TE, Vokes E. Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer. N Engl J Med. 2023 Feb 9;388(6):489-498. doi: 10.1056/NEJMoa2212083.
PubMed 36780674Altorki NK, Wang X, Wigle D, Gu L, Darling G, Ashrafi AS, Landrenau R, Miller D, Liberman M, Jones DR, Keenan R, Conti M, Wright G, Veit LJ, Ramalingam SS, Kamel M, Pass HI, Mitchell JD, Stinchcombe T, Vokes E, Kohman LJ. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). Lancet Respir Med. 2018 Dec;6(12):915-924. doi: 10.1016/S2213-2600(18)30411-9. Epub 2018 Nov 12.
PubMed 30442588
Study at a glance
From the registry record, last updated by the sponsor on 16 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Phase III Randomized Trial of Lobectomy Versus Sublobar Resection for Small (≤ 2 cm) Peripheral Non-Small Cell Lung Cancer
- ClinicalTrials.gov ID
- NCT00499330
- Acronym / sponsor ID
- CALGB 140503
- Conditions
- Lung Cancer
- Keywords
- stage IA non-small cell lung cancer, adenocarcinoma of the lung, squamous cell lung cancer, large cell lung cancer, adenosquamous cell lung cancer, bronchoalveolar cell lung cancer
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Lead sponsor
- Alliance for Clinical Trials in OncologyUniversity, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- Study start
- 12 Oct 2007 (actual)
- Primary completion
- 4 Apr 2027 (estimated)
- Study completion
- 4 Apr 2027 (estimated)
- First posted
- 11 Jul 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
RATIONALE: Wedge resection or segmentectomy may be less invasive types of surgery than lobectomy for non-small cell lung cancer and may have fewer side effects and improve recovery. It is not yet known whether wedge resection or segmentectomy are more effective than lobectomy in treating stage IA non-small cell lung cancer.
PURPOSE: This randomized phase III trial is studying different types of surgery to compare how well they work in treating patients with stage IA non-small cell lung cancer.
Detailed description
OUTLINE: This is a multicenter, randomized study. Patients are stratified according to tumor size (< 1 cm vs 1-1.5 cm vs > 1.5-2.0 cm) (based on the maximum dimension determined from the preoperative CT scan), histology (squamous cell carcinoma vs adenocarcinoma vs other), and smoking status (never smoked [smoked < 100 cigarettes over lifetime] vs former smoker [smoked > 100 cigarettes AND quit ≥ 1 year ago] vs current smoker [quit < 1 year ago or currently smokes]). Patients are randomized to 1 of 2 treatment arms. For more information, please see the Arms section.
Primary Objective:
To determine whether DFS after sublobar resection (segmentectomy or wedge) is non-inferior to that after lobectomy in patients with small peripheral (≤ 2 cm) NSCLC.
Secondary Objectives:
- To determine whether overall survival (OS) (after sublobar resection) is non-inferior to that after lobectomy.
- To determine the rates of loco-regional and systemic recurrence (exclusive of second primaries) after lobar and sublobar resection.
- To determine the difference between the two arms of the study in pulmonary function as determined by expiratory flow rates measured at 6 months post-operatively.
- Imaging Substudy: To explore the relationship between characteristics of the primary lung cancer, as revealed by pre-operative CT and PET imaging, and outcomes; a determination of the false-negative rate of the pre-operative PET scan for identification of involved hilarand mediastinal lymph nodes; and an assessment of the utility of annual follow-up CT imaging after surgical resection of small stage IA NSCLC.
After completion of study treatment, patients are followed up every 6 months for 2 years and then annually for 5 years.
Study design
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Arm A | Other | Procedure: lobectomyPatients undergo a standard operation for lung cancer called a lobectomy. |
| Arm B | Experimental | Procedure: segmentectomy or wedge resectionPatents undergo a limited resection (segentectomy or wedge resection), which a smaller portion of the lung is removed. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| lobectomy | Procedure or surgery | Arm A |
| segmentectomy or wedge resection | Procedure or surgery | Arm B |
Primary outcome
disease-free survival
Time frame: Up to 7 years
3 secondary outcomes
overall survival
Time frame: Up to 7 years
rate of loco-regional and systemic recurrence
Time frame: Up to 7 years
pulmonary function as measured by expiratory flow rate 6 months postoperatively
Time frame: at 6 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Jul 2026.
- Derived from this study: PubMed 42501610Ganti AK, Damman B, Wang X, Stinchcombe TE, Altorki N. Outcomes Based on Age in CALGB 140503 (Alliance): Lobar Versus Sublobar Resection for Peripheral Stage IA Non-small Cell Lung Cancer. Clin Lung Cancer. 2026 Jul 2;27(7):42-49. doi: 10.1016/j.cllc.2026.06.009. Online ahead of print.
- Derived from this study: PubMed 40532782Altorki N, Damman B, Wang X, Liberman M, Wigle D, Ashrafi A, Conti M, Yasufuku K, Schuchert MJ, Stinchcombe TE. The extent of lymph node dissection is not associated with disease-free survival following lobar or sublobar resection: Results from Cancer and Leukemia Group B 140503 (Alliance). J Thorac Cardiovasc Surg. 2025 Oct;170(4):933-942.e2. doi: 10.1016/j.jtcvs.2025.06.007. Epub 2025 Jun 16.
- Derived from this study: PubMed 38215351Stinchcombe TE, Wang X, Damman B, Mentlick J, Landreneau R, Wigle D, Jones DR, Conti M, Ashrafi AS, Liberman M, de Perrot M, Mitchell JD, Keenan R, Bauer T, Miller D, Altorki N. Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung Cancer. J Clin Oncol. 2024 Apr 1;42(10):1110-1113. doi: 10.1200/JCO.23.01306. Epub 2024 Jan 12.
- Derived from this study: PubMed 36780674Altorki N, Wang X, Kozono D, Watt C, Landrenau R, Wigle D, Port J, Jones DR, Conti M, Ashrafi AS, Liberman M, Yasufuku K, Yang S, Mitchell JD, Pass H, Keenan R, Bauer T, Miller D, Kohman LJ, Stinchcombe TE, Vokes E. Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer. N Engl J Med. 2023 Feb 9;388(6):489-498. doi: 10.1056/NEJMoa2212083.
- Derived from this study: PubMed 30442588Altorki NK, Wang X, Wigle D, Gu L, Darling G, Ashrafi AS, Landrenau R, Miller D, Liberman M, Jones DR, Keenan R, Conti M, Wright G, Veit LJ, Ramalingam SS, Kamel M, Pass HI, Mitchell JD, Stinchcombe T, Vokes E, Kohman LJ. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). Lancet Respir Med. 2018 Dec;6(12):915-924. doi: 10.1016/S2213-2600(18)30411-9. Epub 2018 Nov 12.
Related trials for Lung Cancer
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingObservational study
A Prospective ,Multicenter ,Non-interventional ,Real-world Study Observing Changes in Molecular Markers Osimertinib Targeted Therapy in EGFRm NSCLC
Non Small Cell Lung Cancer
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingPhase 3
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Non-Small Cell Lung Cancer (NSCLC)
Active, not recruitingPhase 2
Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer
Metastatic Lung Cancer, Advanced Non Small Cell Lung Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Nasser Altorki, MD study chair
Weill Medical College of Cornell University
386 sites in 3 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing lobectomy and segmentectomy or wedge resection in people with Lung Cancer, run by Alliance for Clinical Trials in Oncology at 386 sites in 3 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 16 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 386 sites in United States, Canada, Australia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
disease-free survival (time frame: Up to 7 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00499330, which also lists 5 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jul 2026; AzTrials last refreshed its copy on 7 Nov 2026.